Hypermarcas (OTCMKTS:HYPMY – Get Free Report)’s share price fell 4% during trading on Monday . The stock traded as low as $4.2250 and last traded at $4.2250. 1,270 shares were traded during mid-day trading, a decline of 98% from the average session volume of 51,829 shares. The stock had previously closed at $4.40.
Hypermarcas Trading Down 4.3%
The business has a 50-day moving average price of $4.51 and a 200-day moving average price of $4.51. The company has a quick ratio of 0.80, a current ratio of 1.27 and a debt-to-equity ratio of 0.61. The firm has a market capitalization of $2.67 billion, a P/E ratio of 18.30 and a beta of 0.73.
Hypermarcas (OTCMKTS:HYPMY – Get Free Report) last posted its quarterly earnings results on Wednesday, November 12th. The company reported $0.13 earnings per share for the quarter. The firm had revenue of $408.83 million for the quarter. Hypermarcas had a net margin of 12.03% and a return on equity of 6.89%.
Hypermarcas Company Profile
Hypermarcas SA is a Brazil-based consumer health and pharmaceutical company whose shares trade over the counter in the United States under the symbol HYPMY. Founded in the early 2000s and headquartered in Rio de Janeiro, the company operates as a holding group for a broad portfolio of branded products in the healthcare and personal care sectors.
Through its various subsidiaries, Hypermarcas develops, manufactures and markets prescription and over-the-counter medications, alongside personal care, baby care, home care and nutritional supplement products.
Recommended Stories
- Five stocks we like better than Hypermarcas
- The Fed Pivot Signal Smart Money’s Been Waiting For
- Do not delete, read immediately
- “$6.6 Trillion Of Customer Bank Deposits At Risk”
- Wall Street Stock picker Names #1 Stock of 2026
- How Long Will $1M Last in Retirement?
Receive News & Ratings for Hypermarcas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hypermarcas and related companies with MarketBeat.com's FREE daily email newsletter.
